abstract |
The present disclosure provides formula (I), which is a modulator of the C5a receptor. Or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions and methods of use, including treatment of diseases or disorders associated with pathological activation caused by C5a, and non-pharmaceutical uses. |